Alternative Oseltamivir Dosing Strategies

NCT00334529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: Oseltamivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)